RE:RE:AACR Poster - very interestingThey got all the data together for the new protocal and the Scientific Adv Committee review and decision on whether to proceed and how. Typically you'd compile for a paper, but perhaps since they had to compile it all for the revision, FDA and that SAC, that is the data the investigator decided to publish and talk about. I was certain they would only cover the first part of the trial since that followed the procedures and they had 100% of the data from it. I thougth they'd skip the second part since it was partial data and then just do one more after that data was fully gathered. So this is a surprise to me that they are reviewing all 38 patients that were on it for a few cycles. Will be really interesting to see the data now just to see what they are basing their decisions on.